Oxidative stress and
mitochondrial dysfunction are underpinned for initiating a cascade of toxic events leading to dopaminergic neuronal death in
Parkinson's disease (PD) and identified as vital target for therapeutic intervention.
Curcumin, a potent
antioxidant has been reported to display diverse neuroprotective properties against various
neurodegenerative diseases including PD. In this present study, we investigated the protective effect of
CNB-001, a
pyrazole derivative of
curcumin on
rotenone-induced toxicity and its possible mechanisms in
neuroblastoma SK-N-SH cells.
Rotenone insult significantly reduced cell viability (MTT assay) and resulted in 78 % apoptosis (dual staining) by altering Bcl-2, Bax,
caspase-3, and
cytochrome C expression. Moreover,
rotenone enhanced ROS production and disrupts mitochondrial membrane potential. These resultant phenotypes were distinctly alleviated by
CNB-001. Pretreatment with CNB-001(2 μM) 2 h before
rotenone exposure (100 nM) increased cell viability, decreased ROS formation, maintained normal physiological mitochondrial membrane potential, and reduced apoptosis. Furthermore,
CNB-001 inhibited downstream apoptotic cascade by increasing the expression of vital antiapoptotic
protein Bcl-2 and decreased the expression of Bax,
caspase-3, and
cytochrome C. Collectively, the results suggest that
CNB-001 protects neuronal cell against toxicity through
antioxidant and antiapoptotic properties through its action on mitochondria. Therefore, it may be concluded that
CNB-001 can be further developed as a promising
drug for treatment of PD.